Stock Events

JCR Pharmaceuticals. 

¥906
3
-¥5-0.55% Thursday 06:15

Statistics

Day High
923
Day Low
902
52W High
1,652
52W Low
894
Volume
803,800
Avg. Volume
547,096
Mkt Cap
269.79B
P/E Ratio
18.88
Dividend Yield
2.24%
Dividend
20.33

Upcoming

Dividends

2.24%Dividend Yield
10Y Growth
-0.8%
5Y Growth
-14.36%
3Y Growth
-4.03%
1Y Growth
-4.9%

Earnings

25OctConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-3.29
18.56
40.42
62.27
Expected EPS
0.1
Actual EPS
-3.29

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4552.TSE. It's not an investment recommendation.

About

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
Show more...
CEO
Mr. Shin Ashida
Employees
816
Country
JP
ISIN
JP3701000006

Listings